Electronic cigarettes can be an effective tool to quit smoking: New Zealand PM

Jan.13.2023
Electronic cigarettes can be an effective tool to quit smoking: New Zealand PM
New Zealand PM acknowledges e-cigarettes as effective tools for quitting smoking, encourages safe alternatives for smokers.

New Zealand Prime Minister Jacinda Ardern has acknowledged that e-cigarettes can be an effective tool to help smokers quit, while discussing recent legislation that bans the legal purchase of tobacco for those aged 14 and under.


The Prime Minister of New Zealand stated that continuously increasing tobacco prices will not continue to aid smoking cessation, which is why alternative methods are necessary. She said that the best way to reduce smoking rates is for individuals to not start smoking in the first place.


If they smoke, they must find safe alternatives and quit smoking. That's all," Ardern said.


Speaking of New Zealand's electronic cigarette framework, Ardern acknowledges that e-cigarettes are a successful tool for people to quit smoking.


This actually allows us to push forward further action plans to reduce smoking, as there is an alternative method that has been very successful in helping people quit smoking. We know that e-cigarettes are having an impact on those who are currently quitting. Therefore, it is an important tool," said the Prime Minister of New Zealand.


New Zealand is one of the countries that allows e-cigarettes to be used more freely as a smoking cessation tool. The latest legislation will allow authorized retailers to sell a wider range of e-cigarette related products.


The legislation also requires that electronic cigarette products must obtain government approval before being sold to ensure they meet safety requirements and that the liquid ingredients do not contain any banned substances.


In 2015, a groundbreaking study was released by Public Health England (PHE) regarding electronic cigarettes. The study found that the harm to health caused by e-cigarettes is significantly lower than that caused by tobacco and that they may be a useful tool for smokers trying to quit.


Furthermore, the UK Department of Health and Social Care, along with the Office for Health Improvement and Disparities, have stated in a recent press release that the UK is likely to become the world's first country to prescribe medicinal electronic cigarettes in order to help reduce smoking rates.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

PMI U.S. Says Dothan Factory Closure Reflects Focus on Smoke-Free Business Strategy
PMI U.S. Says Dothan Factory Closure Reflects Focus on Smoke-Free Business Strategy
Philip Morris International U.S. (PMI U.S.) announced that it will close the Swedish Match cigar manufacturing facility on Columbia Highway in Dothan, Alabama. The company said the decision reflects its need to maintain focus on offering reduced-risk, FDA-authorized smoke-free products to legal-aged adult nicotine users in the United States to help them move away from combustible cigarettes.
Mar.30 by 2FIRSTS.ai
 RFK Jr. Spokesman Resigns Over FDA Authorization of Fruit-Flavored Vapes
RFK Jr. Spokesman Resigns Over FDA Authorization of Fruit-Flavored Vapes
Richard Danker, a senior public affairs official in Health Secretary Robert F. Kennedy Jr.’s team, resigned from his role at HHS over the FDA’s recent authorization of fruit-flavored vaping products. In a resignation letter addressed to President Donald Trump, Danker argued that the products could expose minors to nicotine addiction, lung damage, and increased cancer risks, while also conflicting with recent HHS guidance on youth risks associated with flavored nicotine products.
News
May.15
The new regulations on nicotine in Argentina are creating caution, expectations, and doubts about the market, according to a local reference in harm reduction for smoking.
The new regulations on nicotine in Argentina are creating caution, expectations, and doubts about the market, according to a local reference in harm reduction for smoking.
The new Argentine framework for tobacco and nicotine marks a shift from prohibition towards registration, traceability, and health surveillance. Juan Facundo Teme told 2Firsts that adult consumers and some of the commercial sector are cautiously optimistic, although concerns remain about flavors, registration costs, and market access.
May.11
EVO NXT 2026 Opens in Prague as Global NGP Industry Gathers for Two-Day Event
EVO NXT 2026 Opens in Prague as Global NGP Industry Gathers for Two-Day Event
2026 — EVO NXT 2026 officially opened today in Prague, bringing together manufacturers, brand owners, retailers, and decision-makers from across the global next-generation products (NGP) industry. As the event’s official media partner for the fourth consecutive year, 2Firsts is reporting on site, tracking key developments across the exhibition floor, forum agenda, and broader industry discussions.
Apr.17 by 2FIRSTS.ai
Turning Point Brands Reports Q1 2026 Net Sales of $124.3 Million as Modern Oral Net Sales Rise 133%
Turning Point Brands Reports Q1 2026 Net Sales of $124.3 Million as Modern Oral Net Sales Rise 133%
Turning Point Brands reported first-quarter 2026 results on May 7, covering the period ended March 31, 2026. Total consolidated net sales were $124.3 million, up 16.8% year on year. Gross profit was $68.3 million, up 14.6%, while net income fell 19.0% to $11.7 million. Adjusted EBITDA declined 6.5% to $25.9 million.
May.08 by 2FIRSTS.ai
FDA and NIH Release New Wave 8 Restricted-Use PATH Study Data Files
FDA and NIH Release New Wave 8 Restricted-Use PATH Study Data Files
FDA’s Center for Tobacco Products and NIH’s National Institute on Drug Abuse announced that new Wave 8 restricted-use data files from the PATH Study are now available. The files contain data collected between January 2024 and December 2024, including questionnaire data, location characteristics data, and state identifier data.
Apr.17 by 2FIRSTS.ai